Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Cytotoxic phenanthrene and racemosol derivatives from Bauhinia malabarica roots: network pharmacology and in silico mechanistic insights.

Created on 10 Sep 2026

Authors

Natchaya Sawatdirak, Lueacha Tabtimmai, Sutin Kaennakam, Prasat Kittakoop, Anupong Joompang, Supachai Jadsadajerm, Awat Wisetsai

Published in

Phytochemistry. Pages 115080. Sep 09, 2026. Epub Sep 09, 2026.

Abstract

Phytochemical investigation of the roots of Bauhinia malabarica led to the isolation of ten compounds, including three previously unreported phenanthrene and racemosol derivatives, malathrene A, a rare phenanthrene derivative featuring an unprecedented C-1'-O-C-4 ether bridge, malasol A, and bauhinol B, together with an unreported natural product racemosol derivative, 9-O-methylracemosol, and six known compounds. Their structures were elucidated by spectroscopic methods, including IR, 1D and 2D NMR, and mass spectrometry, while the absolute configurations of malasol A and 9-O-methylracemosol were determined by electronic circular dichroism. Biological evaluation revealed that racemosol exhibited the most potent cytotoxic activity against HeLa cells (IC50 = 4.51 μM) and induced apoptosis in a dose-dependent manner. Network pharmacology analysis suggested that its cytotoxic effect is associated with modulation of multiple signaling pathways, particularly PI3K-Akt and MAPK pathways. Molecular docking indicated that racemosol interacts with the ATP-binding site of the EGFR kinase domain, supporting its potential role as a tyrosine kinase inhibitor. These findings expand the chemical diversity of racemosol-related natural products and highlight racemosol as a promising lead compound for future pharmacological studies.

PMID:
42716268
Bibliographic data and abstract were imported from PubMed on 10 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement